Cargando…
Real-world performance analysis of a novel computational method in the precision oncology of pediatric tumors
BACKGROUND: The utility of routine extensive molecular profiling of pediatric tumors is a matter of debate due to the high number of genetic alterations of unknown significance or low evidence and the lack of standardized and personalized decision support methods. Digital drug assignment (DDA) is a...
Autores principales: | Vodicska, Barbara, Déri, Júlia, Tihanyi, Dóra, Várkondi, Edit, Kispéter, Enikő, Dóczi, Róbert, Lakatos, Dóra, Dirner, Anna, Vidermann, Mátyás, Filotás, Péter, Szalkai-Dénes, Réka, Szegedi, István, Bartyik, Katalin, Gábor, Krisztina Míta, Simon, Réka, Hauser, Péter, Péter, György, Kiss, Csongor, Garami, Miklós, Peták, István |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497647/ https://www.ncbi.nlm.nih.gov/pubmed/36914906 http://dx.doi.org/10.1007/s12519-023-00700-2 |
Ejemplares similares
-
Efficacy of Incremental Next-Generation ALK Inhibitor Treatment in Oncogene-Addicted, ALK-Positive, TP53-Mutant NSCLC
por: Urbán, László, et al.
Publicado: (2020) -
Personalized First-Line Treatment of Metastatic Pancreatic Neuroendocrine Carcinoma Facilitated by Liquid Biopsy and Computational Decision Support
por: Szkukalek, Judita, et al.
Publicado: (2021) -
A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial
por: Petak, Istvan, et al.
Publicado: (2021) -
Clinical Course of COVID-19 Disease in Children Treated With Neoplastic Diseases in Hungary
por: Müller, Judit, et al.
Publicado: (2022) -
Molecular subtype specific efficacy of MEK inhibitors in pancreatic cancers
por: Brauswetter, Diána, et al.
Publicado: (2017)